Changes in Complementary and Alternative Medicine Use Across Cancer Treatment and Relationship to Stress, Mood, and Quality of Life

Kang, Duck Hee; McArdle, Traci; Suh, Yeon Ok

doi:10.1089/acm.2014.0216

Cited by 26 publications

(28 citation statements)

References 32 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Our data also suggest that religious patients are more interested in CAM therapies since they might seek more integrative/ holistic approaches. Kang et al [24] showed that CAM use was highly prevalent in women with breast cancer throughout the cancer treatment. Prayer was the most common CAM; it had the highest satisfaction rates.…”

Section: Discussion/conclusionmentioning

confidence: 99%

Prevalence and Predictors for Nonuse of Complementary Medicine among Breast and Gynecological Cancer Patients

Paepke

Wiedeck

Hapfelmeier³

et al. 2019

Breast Care

View full text Add to dashboard Cite

Background: Complementary and alternative medicine (CAM) use is common among cancer patients. Data indicated that CAM use correlates with younger age, higher education levels, higher income, and less physician consultations. However, non-CAM use and predictors for non-CAM use are less clear among breast and gynecological cancer patients. Objectives: The purpose of this study was to determine the prevalence of non-CAM use and to investigate factors that might influence non-CAM use. Methods: The survey was conducted in breast cancer patients from January to May 2013 and in gynecological cancer patients from January to May 2014 with 2 pseudoanonymous questionnaires: one for CAM users (109 questions) and one for non-CAM users (85 questions). The survey was conducted via a telephone interview with 333 patients. Eligible participants were women with breast cancer (n = 285) and gynecological cancer (n = 291) who had undergone surgery at the Department of Gynecology and Obstetrics at the Technical University Munich, Germany, in the years 2012 (breast cancer) and 2011-2013 (gynecological cancer). Descriptive statistics were generated to determine patterns of non-CAM use. Univariable analysis was used to detect patient characteristics associated with noninterest in the different CAM therapies. Results: A total of 333 of 576 patients participated in the survey (58%). Fifty-eight percent (n = 192/333) were diagnosed with breast cancer and 42% (n = 141/333) with gynecological cancer. The overall prevalence of non-CAM use was 42% (n = 139/333). Eighty-one percent (n = 112/139) of the non-CAM users stated to have received no recommendation for CAM use, although 53% (n = 73/139) would have liked to receive information from their physician. As reasons for the nonuse of CAM therapies, 76% (n = 106/139) nonusers declared that they did not believe CAM use was necessary since the conventional therapy was considered sufficient, 44% (n = 61/139) reported a lack of information, 31% (n = 43/139) a fear of fraud, and 22% (n = 31/139) a fear of interactions and side effects of CAM. Sixty-eight percent (n = 95/139) of the patients stated that they would resort to CAM if the disease progressed while only 27% (n = 37/139) would still not use any CAM with progression of disease. Five percent (7/139) did not give any information regarding possible future CAM use with disease progression. Seventy-three percent (n = 102/139) would both welcome more physicians with qualifications in complementary medicine and supported an integration of CAM into our health care system. Furthermore, statistically significant correlations between patients' sociodemographic characteristics and their nonuse of complementary therapies were identified. Conclusions: Our data demonstrate a high overall interest in CAM even in non-CAM D.P. and C.W. contributed equally to this study as first authors.

show abstract

Section: Discussion/conclusionmentioning

confidence: 99%

Prevalence and Predictors for Nonuse of Complementary Medicine among Breast and Gynecological Cancer Patients

Paepke

Wiedeck

Hapfelmeier³

et al. 2019

Breast Care

View full text Add to dashboard Cite

show abstract

“…While there is a movement toward incorporation of complementary care to improve psychological health in patients with cancer, few evidence-based methods exist to monitor the impact these interventions have on subjective health. 3233 …”

Section: Discussionmentioning

confidence: 99%

Dermal Carotenoid Measurement is Inversely Related to Anxiety in Patients with Breast Cancer

LeCompte

Golod

et al. 2018

Journal of Investigative Medicine

View full text Add to dashboard Cite

Breast cancer is the most prevalent malignancy among women worldwide. Increased oxidative stress and poor subjective health outcomes have been associated with increased risk of cancer recurrence and metastasis, but few studies until now have explored the relationship between oxidative stress and chronic stress/anxiety. This study aims to examine the association between anxiety and a potential dermal correlate of oxidative stress in patients with breast cancer. 102 breast cancer patients were enrolled in a cross-sectional study at Highland Hospital, a county hospital in Oakland, California. Each participant’s skin carotenoid score (SCS), a potential dermal correlate of oxidative stress, was recorded via Raman spectroscopy. Patient demographics, breast cancer stage, and subjective health measures (anxiety and self-rated health) were ascertained. Multivariate linear regression analysis was performed to quantify any associations between SCS and the above health correlates. Higher levels of skin carotenoids were associated with decreased severity of anxiety, lower BMI, increased servings of vegetables/fruits in daily diet, Hispanic race, lower educational status, and nonsmoking status. Severity of anxiety as graded by the GAD-7 was inversely associated with dermal carotenoid measurements via SCS. Conclusions. Increased levels of oxidative stress as quantified by SCS is associated with greater severity of anxiety. Because chronic stress has been associated with tumor progression, increased recurrence rates, and increased metastatic risk in breast cancer, non-invasive dermal carotenoid measurements could be used as a novel objective correlate of subjective health during cancer treatment.

show abstract

“…In Western society, more than 50% to 60% of CAM use is prayer or mindfulness meditation and about 10% use herbal products—suggesting the consideration of nonpharmacological approach to integrative oncology. 3 , 19 In contrast, more than 50% to 70% of patients in China and one-third in Taiwan received co-prescriptions of Chinese herbs to treat their breast cancer, with no awareness of potential herb-drug interaction. 9 , 10 There is evidence that many Chinese herbal extracts might upregulate ERα and HER2 gene expression in vitro 20 , 21 and interact with tamoxifen in vivo .…”

Section: Discussionmentioning

confidence: 99%

Building an Integrative Outpatient Care Program for Breast Cancer Patients in Taiwan

Lin¹,

Shiu²,

Chen

et al. 2016

Integr Cancer Ther

View full text Add to dashboard Cite

Background. Breast cancer patients may experience various symptoms that affect the quality of life significantly and they seek complementary and alternative medicine (CAM). To meet the needs of patients, we developed an integrative outpatient care program. Methods. This program provided CAM consultation and acupuncture for breast cancer patients at Taipei Veterans General Hospital. The outcome measures included Medical Outcomes Study 12-Item Short-Form Health Survey (SF-12) and patient satisfaction questionnaires on the first visit (baseline) and at 6 months. Results. Forty-five breast cancer patients were enrolled. All patients completed the study. The median age was 53.3 (±8.3). The symptoms most often experienced during previous cancer treatments were fatigue (35.6%), arthralgia (20%), nausea (6.7%), and insomnia (6.7%). The symptoms most wished to be diminished by the patients were arthralgia (22.2%), insomnia (17.8%), and fatigue (15.6%). Thirty-four patients (75.6%) had sought CAM therapy to reduce these symptoms. Fifteen patients (33.3%) received CAM consultation only and 30 (66.7%) received acupuncture in addition. Sixteen patients completed at least 6 sessions of acupuncture. No serious adverse effect was reported. In the SF-12 Questionnaire on all the patients, physical component summary (PCS) was 49.6 (±5.6) at baseline and 44.9 (±7.6) at 6 months (P = .001); the mental component summary (MCS) was 44.7 (±6.1) at baseline and 52.3 (±9.3) at 6 months (P < .001). For patients who had completed acupuncture, PCS was 49.2 (±4.9) at baseline and 41.4 (±7.6) at 6 months (P = .148); the MCS was 45.6 (±6.2) at baseline and 49.7 (±11) at 6 months (P = .07). Thirty-eight (84.4%) patients were satisfied with this program. Conclusions. Our results demonstrated that an integrative outpatient care program of conventional and Chinese medicine is feasible. Most patients were satisfied with this program and the quality of life was improved. It is important to conduct more research to build a model that integrates CAM with conventional medicine in Taiwan.

show abstract

Changes in Complementary and Alternative Medicine Use Across Cancer Treatment and Relationship to Stress, Mood, and Quality of Life

Cited by 26 publications

References 32 publications

Prevalence and Predictors for Nonuse of Complementary Medicine among Breast and Gynecological Cancer Patients

Prevalence and Predictors for Nonuse of Complementary Medicine among Breast and Gynecological Cancer Patients

Dermal Carotenoid Measurement is Inversely Related to Anxiety in Patients with Breast Cancer

Building an Integrative Outpatient Care Program for Breast Cancer Patients in Taiwan

Contact Info

Product

Resources

About